| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 45.585 | 73.913 | 111.343 | 147.744 |
| Total Income - EUR | - | - | - | - | - | 0 | 45.585 | 73.913 | 111.343 | 147.744 |
| Total Expenses - EUR | - | - | - | - | - | 72 | 1.959 | 4.601 | 29.691 | 62.130 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -72 | 43.626 | 69.312 | 81.652 | 85.613 |
| Net Profit/Loss - EUR | - | - | - | - | - | -72 | 42.258 | 67.298 | 80.703 | 81.402 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Remizowschi-Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 83.175 | 70.961 |
| Current Assets | - | - | - | - | - | 41 | 43.505 | 68.787 | 77.493 | 126.165 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 4.547 | 4.521 |
| Receivables | - | - | - | - | - | 0 | 41.426 | 67.051 | 67.401 | 83.483 |
| Cash | - | - | - | - | - | 41 | 2.079 | 1.736 | 5.546 | 38.161 |
| Shareholders Funds | - | - | - | - | - | -31 | 42.228 | 67.268 | 91.012 | 81.443 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 72 | 1.277 | 1.520 | 69.656 | 115.684 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Remizowschi-Medical S.r.l.